| Item Type | Name |
|
Concept
|
Prostate-Specific Antigen
|
|
Academic Article
|
Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
|
|
Academic Article
|
Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy.
|
|
Academic Article
|
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
|
|
Academic Article
|
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
|
|
Academic Article
|
Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.
|
|
Academic Article
|
Editorial comment on: Methods of calculating prostate-specific antigen velocity.
|
|
Academic Article
|
Re: Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen. S. Baltaci, E. Suer, A. H. Haliloglu, M. I. Gokce, A. H. Elhan and Y. Beduk. J Urol 2009; 181: 128-132.
|
|
Academic Article
|
Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.
|
|
Academic Article
|
Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
|
|
Academic Article
|
Editorial comment on: Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels.
|
|
Academic Article
|
Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.
|
|
Academic Article
|
Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.
|
|
Academic Article
|
2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
|
|
Academic Article
|
Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program.
|
|
Academic Article
|
Comparison of models to predict clinical failure after radical prostatectomy.
|
|
Academic Article
|
Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results.
|
|
Academic Article
|
Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.
|
|
Academic Article
|
Population-based assessment of prostate-specific antigen testing for prostate cancer in the elderly.
|
|
Academic Article
|
Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting.
|
|
Academic Article
|
Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial.
|
|
Academic Article
|
Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.
|
|
Academic Article
|
Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer.
|
|
Academic Article
|
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
|
|
Academic Article
|
Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.
|
|
Academic Article
|
Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance.
|
|
Academic Article
|
How active should active surveillance be?
|
|
Academic Article
|
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
|
|
Academic Article
|
Prostate Cancer Screening.
|
|
Academic Article
|
Active surveillance monitoring: the role of novel biomarkers and imaging.
|
|
Academic Article
|
Patient-Initiated Prostate Cancer Screening Among Older U.S. Men.
|
|
Academic Article
|
Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project.
|
|
Academic Article
|
Risk of lymph node metastases in pathological gleason score=6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
|
|
Academic Article
|
Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
|
|
Academic Article
|
Low-risk Prostate Cancer: Identification, Management, and Outcomes.
|
|
Academic Article
|
Prostate cancer detection following diagnosis of atypical small acinar proliferation.
|
|
Academic Article
|
Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases.
|
|
Academic Article
|
No Effect of Music on Anxiety and Pain During Transrectal Prostate Biopsies: A Randomized Trial.
|
|
Academic Article
|
Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis.
|
|
Academic Article
|
Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review.
|
|
Academic Article
|
Re: Use of Active Surveillance or Watchful Waiting for Low-risk Prostate Cancer and Management Trends Across Risk Groups in the United States 2010-2015.
|
|
Academic Article
|
Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging.
|
|
Academic Article
|
Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.
|
|
Academic Article
|
Prostate-specific Antigen to Predict Early Success of Focal Therapy: Focusing on Appropriate Endpoints.
|
|
Academic Article
|
Tobacco and marijuana use and their association with serum prostate-specific antigen levels among African American men in Chicago.
|
|
Academic Article
|
Radical Prostatectomy Without Biopsy: Audacious, Imprudent, or Innovative?
|
|
Academic Article
|
Low-Grade Prostate Cancer: Time to Stop Calling It Cancer.
|
|
Academic Article
|
Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy naïve men across racial/ethnic groups.
|
|
Academic Article
|
Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue.
|
|
Academic Article
|
Risk Stratification of Low-risk Prostate Cancer: Individualizing Care in the Era of Active Surveillance.
|
|
Academic Article
|
Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.
|
|
Academic Article
|
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.
|
|
Academic Article
|
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer.
|
|
Academic Article
|
Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial.
|
|
Academic Article
|
Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen.
|
|
Academic Article
|
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction.
|
|
Academic Article
|
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
|